Opportunities Preloader

Please Wait.....

Report

Europe Compression Therapy Market

Market Report I 2025-09-01 I 350 Pages I Data Bridge Market Research

The Europe compression therapy market is expected to reach USD 1,874,419.51 thousand by 2032 from USD 1,302,813.01 thousand in 2024, growing at a substantial CAGR of 4.7% in the forecast period of 2025 to 2032.
Market Segmentation:
Europe Compression Therapy Market, By Product Technique (Static Compression Therapy and Dynamic Compression Therapy), Product Type (Compression Bandages, Garments For Lymphedema, Stockings For Venous Diseases, Compression Wraps, Pneumatic Compression Devices, and Compression Hosiery & Gauntlets), Application (Varicose Veins, Lymphedema, Chronic Venous Insufficiency (CVI), Deep Vein Thrombosis (DVT), Venous Leg Ulcers, Wound Care, and Sports Injury Management), Patient Group (Adult, Geriatric, and Pediatric), Compression Level (Moderate Compression, Strong Compression, Mild Compression, and Very Strong Compression), Distribution Channels (Hospital, Retail Pharmacies, Ecommerce Platforms, Specialty Clinics, Medical Device Stores, Home Healthcare Providers, and Nursing Homes/Long-Term Care Facilities), Country (Germany, U.K., France, Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, rest of Europe) -Industry Trends & Forecast To 2032

Overview of the Europe Compression Therapy are:

Driver

- Increasing Sports Injuries & Accidents
Restrain

- Limited Reimbursement and Insurance Coverage
Opportunity

- Growth In Home Based Therapy

Market Players:

The key market players for Europe Compression Therapy are listed below:

- Solventum (U.S.)
- Cardinal Health (U.S.)
- Smith+Nephew - (U.K.)
- Essity Aktiebolag (publ) (Sweden)
- PAUL HARTMANN AG (Germany)
- Arjo - (Sweden)
- Zimmer Biomet (U.S.)
- NIKE, Inc. (U.S.)
- McKesson Medical-Surgical Inc. (U.S.)
- Getinge (Sweden)
- Convatec Group PLC (U.K.)
- Tactile Medical (U.S.)
- adidas AG (Germany)
- Enovis Corporation (U.S.)
- Molnlycke AB (Sweden)
- Lohmann & Rauscher GmbH & Co. KG (Germany)
- THUASNE, SAS (France)
- SIGVARIS GROUP - (Switzerland)
- Ofa Bamberg GmbH (Germany)
- Medline Industries, LP (U.S.)
- Juzo (Julius Zorn GmbH) (Germany)
- MEDI GmbH & Co. KG (Germany)
- AIROS Medical, Inc. (U.S.)
- Calze G.T. S.r.l (Solidea) (Italy)
- Bauerfeind AG (Germany)
- BIOCOMPRESSION SYSTEMS (U.S.)
- ThermoTek (U.S.)
- Huntleigh Healthcare Limited (U.K.)

TABLE OF CONTENTS
1 INTRODUCTION 51
1.1 OBJECTIVES OF THE STUDY 51
1.2 MARKET DEFINITION 51
1.3 OVERVIEW OF THE EUROPE COMPRESSION THERAPY MARKET 51
1.4 LIMITATIONS 53
1.5 MARKETS COVERED 53
2 MARKET SEGMENTATION 57
2.1 MARKETS COVERED 57
2.2 GEOGRAPHICAL SCOPE 58
2.3 YEARS CONSIDERED FOR THE STUDY 59
2.4 CURRENCY AND PRICING 59
2.5 DBMR TRIPOD DATA VALIDATION MODEL 60
2.6 MULTIVARIATE MODELLING 63
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 64
2.8 DBMR MARKET POSITION GRID 65
2.9 MARKET APPLICATION COVERAGE GRID 66
2.10 VENDOR SHARE ANALYSIS 67
2.11 SECONDARY SOURCES 68
2.12 ASSUMPTIONS 68
3 EXECUTIVE SUMMARY 69
4 PREMIUM INSIGHTS 73
4.1 PESTAL ANALYSIS 75
4.2 PORTERS FIVE FORCES ANALYSIS 76
4.3 COST ANALYSIS BREAKDOWN 77
4.4 HEALTHCARE ECONOMY 78
4.4.1 HEALTHCARE EXPENDITURE 78
4.4.2 CAPITAL EXPENDITURE 78
4.4.3 CAPEX TRENDS 78
4.4.4 CAPEX ALLOCATION 78
4.4.5 FUNDING SOURCES 78
4.4.6 INDUSTRY BENCHMARKS 78
4.4.7 GDP RATIO IN OVERALL GDP 79
4.4.8 HEALTHCARE SYSTEM STRUCTURE 79
4.4.9 GOVERNMENT POLICIES 79
4.4.10 ECONOMIC DEVELOPMENT 79
4.5 INDUSTRY INSIGHTS 80
4.5.1 MICRO AND MACRO ECONOMIC FACTORS 80
4.5.2 PENETRATION AND GROWTH PROSPECT MAPPING 81
4.5.3 KEY PRICING STRATEGIES 82
4.6 INNOVATION TRACKER AND STRATEGIC ANALYSIS 83
4.6.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 83
4.6.1.1 JOINT VENTURES 83
4.6.1.2 MERGERS AND ACQUISITIONS 83
4.6.1.3 LICENSING AND PARTNERSHIP 83
4.6.1.4 TECHNOLOGY COLLABORATIONS 83
4.6.1.5 STRATEGIC DIVESTMENTS 83
4.6.2 NUMBER OF PRODUCTS IN DEVELOPMENT 83
4.6.3 STAGE OF DEVELOPMENT 84
4.6.4 TIMELINES AND MILESTONES 84
4.6.5 INNOVATION STRATEGIES AND METHODOLOGIES 84
4.6.6 RISK ASSESSMENT AND MITIGATION 84
4.6.7 FUTURE OUTLOOK 84
4.7 OPPORTUNITY MAP ANALYSIS 85
4.8 PATENT ANALYSIS - 86
4.8.1 PATENT QUALITY AND STRENGTH 86
4.8.2 PATENT FAMILIES 86
4.8.3 LICENSING AND COLLABORATIONS 87
4.8.4 COMPETITIVE LANDSCAPE 87
4.8.5 IP STRATEGY AND MANAGEMENT 88
4.8.6 OTHER OBSERVATIONS 88
4.9 REIMBURSEMENT FRAMEWORK 90
4.10 SUPPLY CHAIN ECOSYSTEM 91
4.10.1 PROMINENT COMPANIES 91
4.10.2 SMALL & MEDIUM SIZE COMPANIES 92
4.10.3 END USERS 92
4.11 TECHNOLOGY ROADMAP 93
4.12 TARIFFS & IMPACT ON THE MARKET 95
4.12.1 CURRENT TARIFF RATE(S) IN TOP-5 COUNTRY MARKETS 95
4.13 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 96
4.14 VENDOR SELECTION CRITERIA DYNAMICS 96
4.15 IMPACT ON SUPPLY CHAIN 97
4.15.1 RAW MATERIAL PROCUREMENT 97
4.15.2 MANUFACTURING AND PRODUCTION 97
4.15.3 LOGISTICS AND DISTRIBUTION 97
4.15.4 PRICE PITCHING AND POSITION OF MARKET 97
4.16 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 98
4.16.1 SUPPLY CHAIN OPTIMIZATION 98
4.16.2 JOINT VENTURE ESTABLISHMENTS 98
4.17 IMPACT ON PRICES 98
4.18 REGULATORY INCLINATION 98
4.18.1 GEOPOLITICAL SITUATION 98
4.18.2 TRADE PARTNERSHIPS BETWEEN COUNTRIES 98
4.18.2.1 FREE TRADE AGREEMENTS: 98
4.18.2.2 ALLIANCES ESTABLISHMENTS: 98
4.18.3 STATUS ACCREDITATION (INCLUDING MFTN) 99
4.18.4 DOMESTIC COURSE OF CORRECTION 99
4.18.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS: 99
4.18.4.2 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES / INDUSTRIAL PARKS: 99
4.19 PRICE INDEX 99
5 REGULATORY FRAMEWORK 100
6 MARKET OVERVIEW 110
6.1 DRIVERS 112
6.1.1 RISING PREVALENCE OF CHRONIC VENOUS DISORDERS GLOBALLY 112
6.1.2 TECHNOLOGICAL ADVANCEMENTS AND PRODUCT INNOVATION 112
6.1.3 INCREASING SPORTS INJURIES & ACCIDENTS 113
6.1.4 INCREASING AWARENESS OF THERAPY BENEFITS 114
6.2 RESTRAINTS 115
6.2.1 LIMITED REIMBURSEMENT AND INSURANCE COVERAGE 115
6.2.2 AVAILABILITY OF ALTERNATIVE TREATMENT 116
6.3 OPPORTUNITIES 117
6.3.1 GROWTH IN HOME BASED THERAPY 117
6.3.2 POST-SURGICAL CARE & REHABILITATION 117
6.3.3 RISING LIFESTYLE-RELATED DISEASES 118
6.4 CHALLENGES 119
6.4.1 LACK OF STANDARDIZED THERAPY PROTOCOLS 119
6.4.2 ENSURING ACCURATE PRODUCT FIT AND CORRECT APPLICATION 120
7 EUROPE COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE 121
7.1 OVERVIEW 122
7.2 STATIC COMPRESSION THERAPY 125
7.2.1 COMPRESSION STOCKINGS 126
7.2.2 COMPRESSION BANDAGES 126
7.2.3 COMPRESSION SLEEVES 126
7.2.4 COMPRESSION WRAPS 126
7.2.5 COMPRESSION GLOVES/GAUNTLETS 126
7.3 DYNAMIC COMPRESSION THERAPY 127
7.3.1 PNEUMATIC COMPRESSION DEVICES 127
7.3.2 ADAPTIVE COMPRESSION THERAPY DEVICES 127
8 EUROPE COMPRESSION THERAPY MARKET, BY PRODUCT TYPE 128
8.1 OVERVIEW 129
8.2 COMPRESSION BANDAGES 133
8.2.1 SHORT STRETCH BANDAGES 134
8.2.2 LONG STRETCH BANDAGES 134
8.2.3 MULTILAYER COMPRESSION BANDAGES 134
8.3 COMPRESSION GARMENTS FOR LYMPHEDEMA 135
8.3.1 LEG GARMENTS 136
8.3.2 ARM SLEEVES 136
8.3.3 HAND GLOVES 136
8.3.4 TORSO/TRUNK GARMENTS 136
8.3.5 FACE/HEAD GARMENTS 136
8.4 COMPRESSION STOCKINGS FOR VENOUS DISEASES 137
8.4.1 BELOW KNEE STOCKINGS 138
8.4.2 THIGH HIGH STOCKINGS 138
8.4.3 PANTYHOSE/FULL LEG STOCKINGS 138
8.4.4 MATERNITY STOCKINGS 138
8.5 COMPRESSION WRAPS 138
8.6 PNEUMATIC COMPRESSION DEVICES 139
8.7 COMPRESSION HOSIERY & GAUNTLETS 139
9 EUROPE COMPRESSION THERAPY MARKET, BY APPLICATION 140
9.1 OVERVIEW 141
9.2 VARICOSE VEINS 145
9.3 LYMPHEDEMA 145
9.4 CHRONIC VENOUS INSUFFICIENCY (CVI) 146
9.5 DEEP VEIN THROMBOSIS (DVT) 146
9.6 VENOUS LEG ULCERS 147
9.7 WOUND CARE 147
9.8 SPORTS INJURY MANAGEMENT 148
10 EUROPE COMPRESSION THERAPY MARKET, BY PATIENT GROUP 149
10.1 OVERVIEW 150
10.2 ADULT 153
10.3 GERIATRIC 154
10.4 PEDIATRIC 154
11 EUROPE COMPRESSION THERAPY MARKET, BY COMPRESSION LEVEL 155
11.1 OVERVIEW 156
11.2 MODERATE COMPRESSION 159
11.3 STRONG COMPRESSION 160
11.4 MILD COMPRESSION 161
11.5 VERY STRONG COMPRESSION 161
12 EUROPE COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNELS 162
12.1 OVERVIEW 163
12.2 HOSPITALS 167
12.2.1 BANDAGES 168
12.2.2 POST-OPERATIVE COMPRESSION STOCKINGS 168
12.2.3 PNEUMATIC COMPRESSION DEVICES 168
12.3 RETAIL PHARMACIES 168
12.3.1 MILD TO MODERATE COMPRESSION STOCKINGS 169
12.3.2 COMPRESSION BANDAGES 169
12.3.3 SLEEVES AND GAUNTLETS 169
12.4 ECOMMERCE PLATFORMS 170
12.4.1 COMPRESSION STOCKINGS & GARMENTS 171
12.4.2 COMPRESSION WRAPS 171
12.4.3 SLEEVES, GLOVES, AND SOCKS 171
12.4.4 PORTABLE PNEUMATIC DEVICES 171
12.5 SPECIALTY CLINICS 171
12.5.1 HIGH-PRESSURE COMPRESSION GARMENTS 172
12.5.2 PNEUMATIC COMPRESSION PUMPS 172
12.5.3 CUSTOM WRAPS 172
12.6 MEDICAL DEVICE STORES 173
12.6.1 COMPRESSION STOCKINGS 174
12.6.2 COMPRESSION BANDAGES 174
12.6.3 COMPRESSION WRAPS 174
12.6.4 PNEUMATIC COMPRESSION DEVICES 174
12.6.5 ADAPTIVE COMPRESSION SYSTEMS 174
12.7 HOME HEALTHCARE PROVIDERS 175
12.7.1 COMPRESSION WRAPS 176
12.7.2 SLEEVES & GARMENTS 176
12.7.3 BANDAGES 176
12.7.4 PNEUMATIC PUMPS (PORTABLE) 176
12.8 NURSING HOMES/LONG-TERM CARE FACILITIES 176
12.8.1 COMPRESSION WRAPS 177
12.8.2 SLEEVES AND GAUNTLETS 177
12.8.3 ADAPTIVE GARMENTS 177
13 EUROPE COMPRESSION THERAPY MARKET, BY REGION 178
13.1 EUROPE 180
13.1.1 GERMANY 188
13.1.2 FRANCE 195
13.1.3 U.K. 201
13.1.4 ITALY 207
13.1.5 SPAIN 213
13.1.6 SWITZERLAND 219
13.1.7 RUSSIA 225
13.1.8 BELGIUM 231
13.1.9 NETHERLANDS 237
13.1.10 TURKEY 243
13.1.11 REST OF EUROPE 249
14 EUROPE COMPRESSION THERAPY MARKET: COMPANY LANDSCAPE 250
14.1 COMPANY SHARE ANALYSIS: EUROPE 250
15 SWOT ANALYSIS 251
16 COMAPANY PROFILES 252
16.1 SOLVENTUM 252
16.1.1 COMPANY SNAPSHOT 252
16.1.2 REVENUE ANALYSIS 252
16.1.3 COMPANY SHARE ANALYSIS 253
16.1.4 PRODUCT PORTFOLIO 253
16.1.5 RECENT DEVELOPMENT 253
16.2 CARDINAL HEALTH 254
16.2.1 COMPANY SNAPSHOT 254
16.2.2 REVENUE ANALYSIS 254
16.2.3 COMPANY SHARE ANALYSIS 255
16.2.4 PRODUCT PORTFOLIO 255
16.2.5 RECENT DEVELOPMENT 256
16.3 SMITH+NEPHEW 257
16.3.1 COMPANY SNAPSHOT 257
16.3.2 REVENUE ANALYSIS 257
16.3.3 COMPANY SHARE ANALYSIS 258
16.3.4 PRODUCT PORTFOLIO 258
16.3.5 RECENT DEVELOPMENT 259
16.4 ESSITY AKTIEBOLAG (PUBL) 260
16.4.1 COMPANY SNAPSHOT 260
16.4.2 REVENUE ANALYSIS 260
16.4.3 COMPANY SHARE ANALYSIS 261
16.4.4 PRODUCT PORTFOLIO 261
16.4.5 RECENT DEVELOPMENT 263
16.5 PAUL HARTMANN AG 264
16.5.1 COMPANY SNAPSHOT 264
16.5.2 REVENUE ANALYSIS 264
16.5.3 COMPANY SHARE ANALYSIS 265
16.5.4 PRODUCT PORTFOLIO 265
16.5.5 RECENT DEVELOPMENT 265
16.6 ADIDAS AG 266
16.6.1 COMPANY SNAPSHOT 266
16.6.2 REVENUE ANALYSIS 266
16.6.3 PRODUCT PORTFOLIO 267
16.6.4 RECENT DEVELOPMENT 267
16.7 AIROS MEDICAL, INC. 268
16.7.1 COMPANY SNAPSHOT 268
16.7.2 PRODUCT PORTFOLIO 268
16.7.3 RECENT DEVELOPMENT 269
16.8 ARJO 270
16.8.1 COMPANY SNAPSHOT 270
16.8.2 REVENUE ANALYSIS 270
16.8.3 PRODUCT PORTFOLIO 271
16.8.4 RECENT DEVELOPMENTS 271
16.9 BAUERFEIND 272
16.9.1 COMPANY SNAPSHOT 272
16.9.2 PRODUCT PORTFOLIO 272
16.9.3 RECENT DEVELOPMENT 273
16.10 BIOCOMPRESSION SYSTEMS 274
16.10.1 COMPANY SNAPSHOT 274
16.10.2 PRODUCT PORTFOLIO 274
16.10.3 RECENT DEVELOPMENT 274
16.11 CALZE G.T.S.R.L 275
16.11.1 COMPANY SNAPSHOT 275
16.11.2 PRODUCT PORTFOLIO 275
16.11.3 RECENT DEVELOPMENT 276
16.12 CONVATEC GROUP PLC 277
16.12.1 COMPANY SNAPSHOT 277
16.12.2 PRODUCT PORTFOLIO 277
16.12.3 RECENT DEVELOPMENT 278
16.13 ENOVIS CORPORATION 279
16.13.1 COMPANY SNAPSHOT 279
16.13.2 REVENUE ANALYSIS 279
16.13.3 BRAND PORTFOLIO 280
16.13.4 RECENT DEVELOPMENTS 280
16.14 GETINGE 281
16.14.1 COMPANY SNAPSHOT 281
16.14.2 REVENUE ANALYSIS 281
16.14.3 PRODUCT PORTFOLIO 282
16.14.4 RECENT DEVELOPMENT 282
16.15 HUNTLEIGH HEALTHCARE LIMITED 283
16.15.1 COMPANY SNAPSHOT 283
16.15.2 PRODUCT PORTFOLIO 283
16.15.3 RECENT DEVELOPMENT 284
16.16 JUZO 285
16.16.1 COMPANY SNAPSHOT 285
16.16.2 PRODUCT PORTFOLIO 285
16.16.3 RECENT DEVELOPMENT 286
16.17 LOHMANN & RAUSCHER GMBH & CO. KG 287
16.17.1 COMPANY SNAPSHOT 287
16.17.2 PRODUCT PORTFOLIO 287
16.17.3 RECENT DEVELOPMENT 288
16.18 MCKESSON MEDICAL-SURGICAL INC. 289
16.18.1 COMPANY SNAPSHOT 289
16.18.2 REVENUE ANALYSIS 290
16.18.3 PRODUCT PORTFOLIO 290
16.18.4 RECENT DEVELOPMENT 291
16.19 MEDLINE INDUSTRIES, LP 292
16.19.1 COMPANY SNAPSHOT 292
16.19.2 PRODUCT PORTFOLIO 292
16.19.3 RECENT DEVELOPMENTS 293
16.20 MEDI GMBH & CO. KG 294
16.20.1 COMPANY SNAPSHOT 294
16.20.2 PRODUCT PORTFOLIO 294
16.20.3 RECENT DEVELOPMENT 295
16.21 MEGO AFEK LTD. 296
16.21.1 COMPANY SNAPSHOT 296
16.21.2 PRODUCT PORTFOLIO 296
16.21.3 RECENT DEVELOPMENT 298
16.22 MOLNLYCKE AB 299
16.22.1 COMPANY SNAPSHOT 299
16.22.2 PRODUCT PORTFOLIO 299
16.22.3 RECENT DEVELOPMENT 300
16.23 NIKE, INC. 301
16.23.1 COMPANY SNAPSHOT 301
16.23.2 REVENUE ANALYSIS 301
16.23.3 PRODUCT PORTFOLIO 302
16.23.4 RECENT DEVELOPMENT 302
16.24 OFA BAMBERG GMBH 303
16.24.1 COMPANY SNAPSHOT 303
16.24.2 PRODUCT PORTFOLIO 303
16.24.3 RECENT DEVELOPMENT 304
16.25 OSSUR 305
16.25.1 COMPANY SNAPSHOT 305
16.25.2 RECENT FINANCIALS 305
16.25.3 PRODUCT PORTFOLIO 306
16.25.4 RECENT DEVELOPMENT 307
16.26 SIGVARIS GROUP 308
16.26.1 COMPANY SNAPSHOT 308
16.26.2 PRODUCT PORTFOLIO 308
16.26.3 RECENT DEVELOPMENT 308
16.27 TACTILE MEDICAL 309
16.27.1 COMPANY SNAPSHOT 309
16.27.2 REVENUE ANALYSIS 309
16.27.3 PRODUCT PORTFOLIO 310
16.27.4 RECENT DEVELOPMENT 310
16.28 THERMOTEK 312
16.28.1 COMPANY SNAPSHOT 312
16.28.2 PRODUCT PORTFOLIO 312
16.28.3 RECENT DEVELOPMENT 312
16.29 THUASNE, SAS 313
16.29.1 COMPANY SNAPSHOT 313
16.29.2 PRODUCT PORTFOLIO 313
16.29.3 RECENT DEVELOPMENT 313
16.30 ZIMMER BIOMET 314
16.30.1 COMPANY SNAPSHOT 314
16.30.2 REVENUE ANALYSIS 315
16.30.3 PRODUCT PORTFOLIO 315
16.30.4 RECENT DEVELOPMENTS 316
17 QUESTIONNAIRE 317
18 RELATED REPORTS 321
?

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE